CAH
Cardinal Health, Inc. · Healthcare · Medical - Distribution
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -1.0% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 96.00K | $22.40M | n/a | −1 |
| Q2 2026 | 169 | +5 | 162.32M | $38.54B | +9 | −6 |
| Q1 2026 | 169 | -3 | 156.75M | $33.07B | n/a | −4 |
| Q4 2025 | 171 | +1 | 178.08M | $36.60B | +2 | n/a |
| Q3 2025 | 22 | 0 | 113.76M | $17.85B | +1 | −2 |
| Q2 2025 | 20 | 0 | 103.35M | $17.36B | +1 | −1 |
| Q1 2025 | 17 | -1 | 36.99M | $5.09B | n/a | −1 |
| Q4 2024 | 18 | 0 | 42.27M | $5.00B | +1 | −1 |
| Q3 2024 | 17 | 0 | 26.27M | $2.90B | n/a | n/a |
| Q2 2024 | 17 | n/a | 25.18M | $2.47B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 30.58M | n/a | $5.14B | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 30.55M | n/a | $5.13B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passive) | 12.67M | -2.8% | $2.13B | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 6.39M | +3.3% | $1.07B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 6.27M | n/a | $1.05B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 6 | Norges Bank ✦ (passive) | 3.48M | +68.1% | $584.42M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.29M | -3.9% | $385.14M | 0.1% | ▼ Trim | 5 | SEC ↗ ×6 |
| 8 | Marshall Wace ✦ | 1.93M | +19.1% | $324.40M | 0.4% | ▲ Add | 5 | SEC ↗ ×3 |
| 9 | T. Rowe Price ✦ | 1.63M | -1.4% | $274.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 1.42M | -18.3% | $238.43M | 0.2% | ▼ Trim | 5 | SEC ↗ ×7 |
| 11 | Millennium Management ✦ | 1.28M | -9.1% | $214.66M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.05M | -63.1% | $176.83M | 0.2% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Two Sigma Investments ✦ | 998.15K | +1.4% | $167.69M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 856.28K | -32.6% | $143.85M | 0.2% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Point72 Asset Management ✦ | 691.26K | -30.1% | $116.13M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 658.41K | +5.6% | $110.61M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 258.75K | +258.0% | $43.47M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 218.60K | +248.1% | $36.72M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 111.93K | +189.3% | $18.80M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 11.52K | New | $1.94M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $1.94M | 0.0% |
Exited
| Fisher Asset Management | $203,282 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,414 holders, 197.98M shares, $39.62B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 6.73K sh · $1.59M
Officer · 16.19K sh · $3.84M
Officer · 6.24K sh · $1.49M
Officer · 6.21K sh · $1.45M
Officer · 3.46K sh · $809,941
Officer · 5.70K sh · $1.34M
Officer · 100 sh · $23,740
Officer · 2.20K sh · $522,733
Officer · 3.90K sh · $915,096
Officer · 10.25K sh · $2.41M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology